Bayer Withheld Yasmin Data From U.S., Former Agency Chief Says

A Bayer AG unit withheld from U.S. regulators findings by company researchers of increased reports of blood clots in users of its Yasmin birth-control pills, the former head of the Food and Drug Administration said.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.